Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 19 Show results per page	View Search Criteria \| Help With Results

Last Modified: 11/1/1988


1.		Phase I/II Study of Piritrexim (BW 301U) and MTX in Patients with Advanced or Recurrent Head and Neck Cancer (Summary Last Modified 11/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over								MDA-DM-88041 NCI-V88-0519

Last Modified: 11/1/2000 First Published: 3/1/1997


2.		Phase II Study of Piritrexim in Refractory Urothelial Carcinoma (Summary Last Modified 11/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				E-3896 NCT00002914, E3896

Last Modified: 12/15/2008 First Published: 1/1/1998


3.		Phase II Study of Oral Piritrexim in Patients with Advanced Carcinoma of the Urothelium Who Have Failed Standard Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				ILEX-PTX201-A1 NCI-V97-1359

Last Modified: 8/1/1999 First Published: 4/1/1999


4.		Phase II Study of Oral Piritrexim in Patients with Refractory Malignant Fibrous Histiocytoma (Summary Last Modified 08/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				Over 18				Pharmaceutical / Industry				ILEX-PTX231 UCLA-HSPC-9807009, NCI-V99-1516


5.		Phase II Chemotherapy with BW-301U in Patients with Metastatic and Recurrent Colorectal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								DUMC-489849 NCI-V85-0001


6.		Phase II Chemotherapy with Piritrexim in Stage II/III Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 18								DUMC-7408611R1 NCI-V85-0262


7.		Phase II Chemotherapy with Piritrexim in Advanced Colorectal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 18								DUMC-7398611R1 NCI-V85-0263

Last Modified: 1/1/1988


8.		Phase II Chemotherapy with Intravenous Piritrexim in Patients with Pancreatic Cancer (Summary Last Modified 01/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								RPMI-DS-8714 NCI-V87-0241

Last Modified: 1/1/1988


9.		Phase II Chemotherapy with Intravenous Piritrexim in Patients with Gastric Cancer (Summary Last Modified 01/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								RPMI-DS-8715 NCI-V87-0240

Last Modified: 4/1/1988


10.		Phase II Chemotherapy with Intravenous Piritrexim in Patients with Biliary Cancer (Biliary Duct or Primary Gall Bladder) (Summary Last Modified 04/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								RPMI-DS-8716 NCI-V87-0250

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute